Freudenberg Medical specializes in metal components such as hypotubes, laser-cut tubes, pullwire assemblies, laser welding and engineered needles for critical applications including cardiovascular, structural heart, peripheral vascular, electrophysiology, and neurovascular devices. Additionally, they hold over 100 technology patents in surface modification and drugdevice solutions, offering extensive expertise in custom drug and functional coatings for applications including drug-eluting stents, drug-coated balloons and lubricious hydrophilic coatings.
“We have long admired Freudenberg Medical for their creativity and dedication to operational excellence,” said Barry Schnur, CEO of DSA. “This partnership is a strategic alignment with a company that brings over 175 years of unparalleled materials science expertise to the MedTech industry — a rarity in our market. It significantly enhances our ability to offer customers even more comprehensive solutions as they develop sophisticated medical devices, especially for minimally invasive and interventional applications.”
“Our partnership with DSA expands the reach of our existing commercial teams and ensures that Freudenberg Medical’s innovative coating solutions and metal components are more accessible at the early stages of device development,” said Michael McGee, CEO of Freudenberg Medical. “This collaboration offers the R&D teams of medical device OEMs faster access to a trusted CDMO with deep clinical acumen, empowering them to design high-performing devices and accelerate their time to market.”
